Notice of Intent to Sole Source: Eurofins Genomics GLP Sequencing

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) intends to award a sole source firm fixed price purchase order to Eurofins Genomics, Louisville, KY 40299, to provide cGLP compliant, bidirectional 2-fold Sanger sequencing of seventeen pairs of plasmids with a final Quality Control (QC) reviewed project report for each pair (34 total). The report must contain full sequence results, primers used, analysis versus expected (target) sequence, and coverage map. This contract action is for services which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-l(b) (SAP) and 10 U.S.C. 2304(c)(l). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received by 4:30PM ET on August 24, 2023 will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist, Brian Swann at contact@example.gov by 4:30PM ET on August 24, 2023.